Q4 2021 Results

Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix IM performing well across geographies in 2021 US USD bn, % CC +5% 15.0 14.3 FY 2020 FY 2021 Key growth drivers Cosentyx®, EntrestoⓇ, KesimptaⓇ YCE AZ KKL 12 Investor Relations | Q4 2021 Results Europe USD bn, % cc 13.5 +8% 14.9 FY 2020 FY 2021 China USD bn, % cc +10% 2.8 2.4 FY 2020 FY 2021 1 GROWTH Key growth drivers EntrestoⓇ, ZolgensmaⓇ, KisqaliⓇ, JakaviⓇ CE ZK K L Key growth drivers Cosentyx, EntrestoⓇ, LucentisⓇ YCE AZ K KL NOVARTIS | Reimagining Medicine

View entire presentation